Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
VentriPoint Diagnostics Ltd
V.VPT
Alternate Symbol(s):
VPTDF
Healthcare
Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in...
oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:VPT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 17, 2024 8:19am
Dr. Pellikka is a cardiologist at Mayo Clinic Nice comment.
American Society of EchocardiographyAmerican Society of Echocardiography26,112 followers26,112 followers 44m • Edited • 44 minutes ago
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 17, 2024 6:11am
VMS+ V3.2 and submitted V4.0 to FDA for 510(k) clearance.
Hugh MacNaughtHugh MacNaught• Following• FollowingPresident and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd. 9h • 9 hours ago
...more
(62)
•••
WalkOverTheStrt
X
View Profile
View Bullboard History
Comment by
WalkOverTheStrt
on Jun 16, 2024 7:08pm
RE:RE:All Aboard !!
Building awareness and use cases on 2024. Sales to be expected but wouldn't expect more than 10-20 (high end of things go really well with bulk sales). Hugh is building the basics and having
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 16, 2024 5:03pm
“3D Echocardiography for the Structural Heart Team!”
For those who denigrated Dr.G.Adams the visionary with Ventripoint...and who now call themselves experts how they would have done with Ventripoint! Interesting to see how far we’ve come all these
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 16, 2024 7:42am
Cybersecurity ESET from Ventripoint Diagnostics Ltd.!
Comment Hugh MacNaught President and CEO at Ventripoint Diagnostics Ltd. 16h Congrats Preet Preet MinhasPreet Minhas • 3rd+ • 3rd+Biomedical Electronics Engineering Technologist
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 16, 2024 7:02am
Hannah Crane for services to the NHS and voluntary work 💙
Hugh MacNaughtHugh MacNaught• Following• FollowingPresident and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd. 15h • 15 hours ago
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 15, 2024 8:11am
RE:RE:RE:RE:RE:RE: Ventripoint’s technology in routine clinical practice”.
More good comment and i buy more 20000 yesterday merci les vendeurs FUD team resumes as abitude will have to work hard to dilute the good news here and ceo ... @Ninja I
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 15, 2024 7:03am
RE:RE:RE:RE:RE: Ventripoint’s technology in routine clinical practice”.
ok et tres positif on the good comments on the translation of my message.
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 14, 2024 4:37pm
RE:RE:RE:RE: Ventripoint’s technology in routine clinical practice”.
% TDGAFAU and good comment @Anima lots of positives. Upcoming potential oversubscription. Ascend update. 4.0 approval in the summer. Brazil coming into play soon. @TDGAFAU
...more
(1538)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 14, 2024 12:54pm
RE:RE:New Press Release - Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management
Hmm, that was bad timing. Volume was up but not a share has traded in 30 minutes since I asked the question.
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 14, 2024 11:54am
RE:RE:RE: Ventripoint’s technology in routine clinical practice”.
good Indonesia, India and Brazil,@budmancubfan They appear to be developing plans and taking a good shot at huge markets including Indonesia, India and Brazil. Huge numbers of sales
...more
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 14, 2024 11:51am
RE:RE: Ventripoint’s technology in routine clinical practice”.
Merci Anima @Anima Hugh also mentioned we can expect and update about ascend collab soon. 6 minutes ago
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Comment by
jopatclo
on Jun 14, 2024 11:43am
RE: Ventripoint’s technology in routine clinical practice”.
Good comment nicolaost @nicolaosK Well thats something new. Cashflow positive projection 1 13 minutes ago @nicolaosK Any
...more
(1538)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 14, 2024 11:31am
RE:New Press Release - Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management
Was there a conference call this morning? I see volume is up and price is down. Is that a reaction to the CC? Even Jo is not commenting.
(91)
•••
jopatclo
X
View Profile
View Bullboard History
Post by
jopatclo
on Jun 13, 2024 9:45am
Ventripoint’s technology in routine clinical practice”.
“Matt has excelled in past assignments and will be key in evolving Ventripoint to becoming a market driven organization,” said Ventripoint’s CEO Hugh MacNaught. “Our focus is developing actionable
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Low Cost Natural Gas Producer for Your Portfolio
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions